+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bullous pemphigoid Market - Global Forecast 2026-2032- Product Image
Bullous pemphigoid Market - Global Forecast 2026-2032- Product Image
Sale

Bullous pemphigoid Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011507
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bullous pemphigoid Market is projected to reach USD 402.44 Million in 2026. It is expected to continue growing at a CAGR of 6.08%, reaching USD 574.14 Million by 2032.

Bullous Pemphigoid: Executive Overview of a Complex Autoimmune Skin Disease

Bullous pemphigoid is an autoimmune blistering disorder characterized by tense, often itchy blisters caused by antibodies targeting proteins at the junction between the epidermis and dermis. It primarily affects older adults and may be associated with substantial symptom burden, impaired mobility, sleep disruption, infection risk, and reduced quality of life. Diagnosis generally combines clinical assessment with skin biopsy, direct immunofluorescence, and serologic testing. Management is individualized according to disease severity, comorbidities, frailty, and treatment access.

Diagnosis and Care Are Shifting Toward Earlier, More Individualized Management

Clinical practice is increasingly emphasizing rapid recognition of bullous pemphigoid, confirmation through appropriate immunopathology, and treatment plans that balance disease control against corticosteroid-related harm. Topical or systemic corticosteroids remain important, while steroid-sparing immunosuppressive and anti-inflammatory approaches may be considered for selected patients. Greater attention is also being given to wound care, infection prevention, medication review, fall prevention, nutritional support, and monitoring for complications in older and medically complex populations.

Artificial Intelligence Can Strengthen Recognition, Monitoring, and Research Without Replacing Clinicians

Artificial intelligence may support bullous pemphigoid care through image-assisted lesion classification, extraction of disease activity measures from clinical records, identification of treatment-response patterns, and improved matching of patients to clinical studies. Its practical value depends on representative training data, validated performance across skin tones and care settings, transparent outputs, and integration with specialist judgment. Because misclassification can delay treatment or expose patients to unnecessary immunosuppression, AI tools should remain decision-support systems subject to clinical oversight, privacy safeguards, and post-deployment monitoring.

Regional Care Pathways Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America generally benefits from established dermatology networks, diagnostic laboratories, and access to specialist care, although cost and geographic access can remain barriers. Latin America may face uneven availability of immunofluorescence testing, specialist services, and advanced therapies, making referral pathways and education important. Europe has strong academic dermatology capacity and coordinated clinical guidance, but access and reimbursement vary among countries. The Middle East shows differing levels of specialist concentration and diagnostic infrastructure. Africa requires attention to workforce capacity, referral systems, infection prevention, and affordability. Asia-Pacific combines advanced centers with substantial rural and urban disparities, creating opportunities for teledermatology, standardized diagnostic pathways, and locally validated care protocols.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Members Need Coordinated but Context-Specific Strategies

ASEAN countries can benefit from shared training, referral networks, and approaches adapted to varied health-system resources. BRICS members face diverse epidemiologic, geographic, and financing conditions, supporting collaboration on specialist education, diagnostic access, and real-world evidence. European Union systems can advance harmonized standards while accounting for national reimbursement differences. G7 health systems are positioned to strengthen research, geriatric care integration, and safety monitoring. GCC countries may prioritize specialist capacity, referral coordination, and access to diagnostic testing. NATO members, considered as a broad health-system grouping rather than a single care model, can support preparedness, clinical knowledge exchange, and continuity of care while recognizing substantial differences among members.

Country-Level Priorities Span Specialist Access, Diagnostics, Safety Monitoring, and Equity

Australia can focus on rural access and coordinated dermatology referral. Brazil and Mexico may benefit from expanding diagnostic capacity and specialist training beyond major urban centers. Canada can continue addressing geographic access and culturally responsive care. China and India require scalable diagnostic and referral pathways across highly varied health systems. France, Germany, Italy, Spain, and the United Kingdom can emphasize consistent implementation of evidence-based pathways, geriatric coordination, and treatment-safety surveillance. Japan and South Korea may prioritize aging-population needs, specialist integration, and monitoring of treatment complications. Russia faces the importance of maintaining diagnostic continuity and specialist availability across large geographic areas. The United States can focus on equitable access, care coordination, and evidence generation across diverse clinical settings.

Industry Leaders Should Prioritize Safer Therapies, Diagnostic Access, and Patient-Centered Evidence

Leaders should invest in therapies and care models that reduce reliance on prolonged systemic corticosteroid exposure while preserving disease control. Partnerships with dermatologists, immunologists, geriatricians, nurses, and patient organizations can improve diagnosis, education, adherence, and supportive care. Development programs should use clinically meaningful outcomes, include older adults with comorbidities, and report safety transparently. Organizations should also strengthen access programs, diagnostic training, digital monitoring, and interoperable data collection. Any AI deployment should include bias testing, explainability, human review, cybersecurity, and continuous performance evaluation across regions and skin types.

Research Methodology: Evidence-Based Synthesis of Disease, Care, and System-Level Considerations

This executive summary uses the supplied market topic as the scope and synthesizes established clinical and health-system considerations for bullous pemphigoid. The approach prioritizes peer-reviewed medical literature, clinical practice guidance, regulatory and public-health materials, and documented diagnostic and treatment principles. Findings are organized across disease management, technology, geography, population groupings, and country contexts. No market estimates, market shares, forecasts, or company-specific claims are included. Regional and country observations are framed as health-system considerations rather than assertions of uniform practice or disease burden.

Better Outcomes Depend on Earlier Recognition, Integrated Support, and Responsible Innovation

Bullous pemphigoid requires more than blister suppression: effective care also addresses treatment toxicity, infection risk, frailty, functional decline, mental well-being, and continuity across specialties. The most durable progress will come from combining validated diagnostics, individualized therapy, coordinated supportive care, equitable specialist access, and carefully governed digital tools. Stakeholders that align clinical quality, patient safety, research rigor, and regional realities will be best positioned to improve the experience and outcomes of people living with this serious autoimmune disease.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bullous pemphigoid Market, by Drug Class
7.1. Introduction
7.2. Biologics
7.2.1. Omalizumab
7.2.2. Rituximab
7.3. Corticosteroids
7.3.1. Methylprednisolone
7.3.2. Prednisone
7.4. Immunosuppressants
7.4.1. Azathioprine
7.4.2. Methotrexate
7.4.3. Mycophenolate Mofetil
8. Bullous pemphigoid Market, by Route Of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
8.4. Topical
9. Bullous pemphigoid Market, by Therapy Line
9.1. Introduction
9.2. First Line
9.3. Maintenance
9.4. Second Line
10. Bullous pemphigoid Market, by End User
10.1. Introduction
10.2. Homecare Settings
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Specialty Clinics
10.4.1. Dermatology Clinics
10.4.2. Outpatient Clinics
11. Bullous pemphigoid Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Bullous pemphigoid Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Bullous pemphigoid Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. AbbVie Inc.
15.2. Argenx SE
15.3. AstraZeneca plc
15.4. Bristol-Myers Squibb Company
15.5. Eli Lilly and Company
15.6. F. Hoffmann-La Roche AG
15.7. GlaxoSmithKline plc
15.8. Novartis AG
15.9. Pfizer Inc.
15.10. Regeneron Pharmaceuticals, Inc.
15.11. Sanofi S.A.
15.12. Sun Pharmaceutical Industries Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Bullous pemphigoid Market, Years Considered for the Study
FIGURE 2. Global Bullous pemphigoid Market, Research Design
FIGURE 3. Global Bullous pemphigoid Market, Research Framework
FIGURE 4. Global Bullous pemphigoid Market, Data Triangulation
FIGURE 5. Global Bullous pemphigoid Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Bullous pemphigoid Market Size, by Drug Class, 2025 vs 2032 (%)
FIGURE 7. Global Bullous pemphigoid Market Size, by Drug Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Bullous pemphigoid Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Bullous pemphigoid Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Bullous pemphigoid Market Size, by Therapy Line, 2025 vs 2032 (%)
FIGURE 11. Global Bullous pemphigoid Market Size, by Therapy Line, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Bullous pemphigoid Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Bullous pemphigoid Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Bullous pemphigoid Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Bullous pemphigoid Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Bullous pemphigoid Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Bullous pemphigoid Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Bullous pemphigoid Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Bullous pemphigoid Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Bullous pemphigoid Market Segmentation & Coverage
TABLE 2. Global Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 3. Global Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 4. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Omalizumab Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Omalizumab Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Omalizumab Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Rituximab Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Rituximab Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Rituximab Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Corticosteroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Corticosteroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Corticosteroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Methylprednisolone Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Methylprednisolone Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Methylprednisolone Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Prednisone Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Prednisone Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Prednisone Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Immunosuppressants Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Immunosuppressants Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Immunosuppressants Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Azathioprine Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Azathioprine Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Azathioprine Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Methotrexate Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Methotrexate Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Methotrexate Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Mycophenolate Mofetil Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Mycophenolate Mofetil Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Mycophenolate Mofetil Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 35. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 45. Global First Line Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global First Line Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global First Line Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Maintenance Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Maintenance Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Maintenance Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Second Line Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Second Line Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Second Line Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 55. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Dermatology Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Dermatology Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Dermatology Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Outpatient Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Outpatient Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Outpatient Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Bullous pemphigoid Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Bullous pemphigoid Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 87. North America Bullous pemphigoid Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. North America Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 89. North America Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 90. North America Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 91. North America Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 92. North America Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 93. North America Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 94. North America Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. North America Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 96. North America Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 97. Latin America Bullous pemphigoid Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Latin America Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 99. Latin America Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 100. Latin America Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 101. Latin America Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 102. Latin America Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 103. Latin America Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 104. Latin America Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Latin America Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 106. Latin America Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 107. Europe Bullous pemphigoid Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Europe Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 109. Europe Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 110. Europe Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 111. Europe Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 112. Europe Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 113. Europe Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 114. Europe Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Europe Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 116. Europe Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 117. Middle East Bullous pemphigoid Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Middle East Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 119. Middle East Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 120. Middle East Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 121. Middle East Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 122. Middle East Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 123. Middle East Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 124. Middle East Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. Middle East Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 126. Middle East Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 127. Africa Bullous pemphigoid Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Africa Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 129. Africa Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 130. Africa Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 131. Africa Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 132. Africa Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 133. Africa Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 134. Africa Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Africa Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 136. Africa Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 137. Global Bullous pemphigoid Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. ASEAN Bullous pemphigoid Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. ASEAN Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 140. ASEAN Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 141. ASEAN Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 142. ASEAN Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 143. ASEAN Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 144. ASEAN Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 145. ASEAN Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. ASEAN Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 147. ASEAN Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 148. GCC Bullous pemphigoid Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. GCC Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 150. GCC Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 151. GCC Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 152. GCC Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 153. GCC Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 154. GCC Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 155. GCC Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. GCC Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 157. GCC Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 158. European Union Bullous pemphigoid Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. European Union Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 160. European Union Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 161. European Union Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 162. European Union Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 163. European Union Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 164. European Union Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 165. European Union Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. European Union Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 167. European Union Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 168. BRICS Bullous pemphigoid Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. BRICS Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 170. BRICS Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 171. BRICS Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 172. BRICS Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 173. BRICS Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 174. BRICS Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 175. BRICS Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. BRICS Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 177. BRICS Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 178. G7 Bullous pemphigoid Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. G7 Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 180. G7 Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 181. G7 Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 182. G7 Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 183. G7 Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 184. G7 Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 185. G7 Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. G7 Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 187. G7 Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 188. NATO Bullous pemphigoid Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. NATO Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 190. NATO Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 191. NATO Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 192. NATO Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 193. NATO Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 194. NATO Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 195. NATO Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. NATO Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 197. NATO Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 198. Global Bullous pemphigoid Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. United States Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 200. United States Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 201. United States Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 202. United States Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 203. United States Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 204. United States Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 205. United States Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 206. United States Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. United States Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 208. United States Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 209. Canada Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 210. Canada Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 211. Canada Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 212. Canada Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 213. Canada Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 214. Canada Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 215. Canada Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 216. Canada Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Canada Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 218. Canada Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 219. Mexico Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 220. Mexico Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 221. Mexico Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 222. Mexico Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 223. Mexico Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 224. Mexico Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 225. Mexico Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 226. Mexico Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Mexico Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 228. Mexico Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 229. Brazil Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 230. Brazil Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 231. Brazil Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 232. Brazil Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 233. Brazil Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 234. Brazil Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 235. Brazil Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 236. Brazil Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. Brazil Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 238. Brazil Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 239. United Kingdom Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 240. United Kingdom Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 241. United Kingdom Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 242. United Kingdom Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 243. United Kingdom Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 244. United Kingdom Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 245. United Kingdom Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 246. United Kingdom Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. United Kingdom Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 248. United Kingdom Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 249. Germany Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 250. Germany Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 251. Germany Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 252. Germany Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 253. Germany Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 254. Germany Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 255. Germany Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 256. Germany Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. Germany Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 258. Germany Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 259. France Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 260. France Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 261. France Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 262. France Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 263. France Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 264. France Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 265. France Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 266. France Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. France Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 268. France Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 269. Russia Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 270. Russia Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 271. Russia Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 272. Russia Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 273. Russia Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 274. Russia Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 275. Russia Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 276. Russia Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Russia Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 278. Russia Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 279. Italy Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 280. Italy Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 281. Italy Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 282. Italy Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 283. Italy Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 284. Italy Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 285. Italy Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 286. Italy Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. Italy Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 288. Italy Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 289. Spain Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 290. Spain Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 291. Spain Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 292. Spain Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 293. Spain Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 294. Spain Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 295. Spain Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 296. Spain Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. Spain Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 298. Spain Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 299. China Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 300. China Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 301. China Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 302. China Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 303. China Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 304. China Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 305. China Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 306. China Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. China Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 308. China Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 309. India Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 310. India Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 311. India Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 312. India Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 313. India Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 314. India Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 315. India Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 316. India Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. India Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 318. India Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 319. Japan Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 320. Japan Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 321. Japan Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 322. Japan Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 323. Japan Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 324. Japan Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 325. Japan Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 326. Japan Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 327. Japan Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 328. Japan Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 329. Australia Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 330. Australia Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 331. Australia Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 332. Australia Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 333. Australia Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 334. Australia Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 335. Australia Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 336. Australia Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 337. Australia Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 338. Australia Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 339. South Korea Bullous pemphigoid Market Size, 2017-2032 (USD Million)
TABLE 340. South Korea Bullous pemphigoid Market Size, by Drug Class, 2017-2032 (USD Million)
TABLE 341. South Korea Bullous pemphigoid Market Size, by Biologics, 2017-2032 (USD Million)
TABLE 342. South Korea Bullous pemphigoid Market Size, by Corticosteroids, 2017-2032 (USD Million)
TABLE 343. South Korea Bullous pemphigoid Market Size, by Immunosuppressants, 2017-2032 (USD Million)
TABLE 344. South Korea Bullous pemphigoid Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 345. South Korea Bullous pemphigoid Market Size, by Therapy Line, 2017-2032 (USD Million)
TABLE 346. South Korea Bullous pemphigoid Market Size, by End User, 2017-2032 (USD Million)
TABLE 347. South Korea Bullous pemphigoid Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 348. South Korea Bullous pemphigoid Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 349. Global Bullous pemphigoid Market Share, by Key Player, 2025
TABLE 350. Global Bullous pemphigoid Market, Key Experts

Companies Mentioned

  • AbbVie Inc.
  • Argenx SE
  • AstraZeneca plc
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.

Related Topics

Related Reports

Bullous Pemphigoid - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Bullous Pemphigoid - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Efgartigimod PH20 SC Sales Forecast, and Market Size Analysis - 2034 - Product Image

Efgartigimod PH20 SC Sales Forecast, and Market Size Analysis - 2034

  • Report
  • 30 Pages
  • Global
From
Immunosuppressants Market - Global Forecast 2026-2032 - Product Image

Immunosuppressants Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Atopic Dermatitis Drugs Market - Global Forecast 2026-2032 - Product Image

Atopic Dermatitis Drugs Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Autoimmune Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Autoimmune Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.